Biotech Holdings LtdShs Aktie
WKN DE: 925970 / ISIN: CA0909381018
20.10.2025 02:58:24
|
J.L. Bainbridge Exits Most of Biogen Stake as Biotech Stock Eyes Turnaround
Florida-based wealth advisory J. L. Bainbridge & Co. sold 119,376 shares of Biogen (NASDAQ:BIIB) during the third quarter for an estimated $16.1 million.In a quarterly disclosure filed with the Securities and Exchange Commission on Friday, J. L. Bainbridge & Co. Inc. reported selling 119,376 shares of Biogen (NASDAQ:BIIB) during the third quarter. The estimated value of the shares sold was $16.1 million, based on the average closing price for the period. The fund now holds just 2,969 shares of Biogen valued at $415,898 as of September 30.The sale reduced Biogen to 0.03% of reported U.S. equity assets under management as of September 30. Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!